Pure Global
NCT06345963

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

The University of Texas Health Science Center, Houston·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Schizophrenia
Drug/Device/Intervention
active H-coil delivered rTMS
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
The University of Texas Health Science Center, Houston
Location
Houston, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
May 01, 2030
Enrollment
120 participants
Primary outcome

brain microstructural integrity from magnetic resonance imaging (MRI),Resting-state functional connectivity (rsFC) from functional MRI

Summary

Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive
 transcranial magnetic stimulation (rTMS) from H coil for improving white matter integrity.

ICD-10 classifications
SchizophreniaSimple schizophreniaSchizophrenia, unspecifiedOther schizophreniaParanoid schizophrenia
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06345963
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06345963 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Texas Health Science Center, Houston and is currently Not yet recruiting. The study focuses on Schizophrenia. Target enrollment is 120 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.